Crescent Biopharma Inc.

CUSIP 38000Q201COMCBIOQ4 2025

Crescent Biopharma Inc. — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.3%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

5 filings · latest Oct 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Oct 14, 2025	1globe Capital LLC	13G/A	10.3%	1.43M	SEC
2	Aug 20, 2025	1globe Capital LLC	13G	6.5%	896.7K	SEC
3	Jul 8, 2025	Fmr LLC	13G	10.2%	1.41M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Quadrature Capital Ltd	13.2K	$157.1K
2	Remedium Capital Partners, LLC	361.3K	$4.3K